Repository logo

Meal phosphate variability does not support fixed dose phosphate binder schedules for patients treated with peritoneal dialysis: a prospective cohort study

dc.contributor.authorLeung, Simon
dc.contributor.authorMcCormick, Brendan
dc.contributor.authorWagner, Jessica
dc.contributor.authorBiyani, Mohan
dc.contributor.authorLavoie, Susan
dc.contributor.authorImtiaz, Rameez
dc.contributor.authorZimmerman, Deborah
dc.date.accessioned2015-12-09T07:02:46Z
dc.date.available2015-12-09T07:02:46Z
dc.date.issued2015-12-09
dc.date.updated2015-12-09T07:02:46Z
dc.description.abstractAbstract Background Removal of phosphate by peritoneal dialysis is insufficient to maintain normal serum phosphate levels such that most patients must take phosphate binders with their meals. However, phosphate ‘counting’ is complicated and many patients are simply prescribed a specific dose of phosphate binders with each meal. Therefore, our primary objective was to assess the variability in meal phosphate content to determine the appropriateness of this approach. Methods In this prospective cohort study, adult patients with ESRD treated with peritoneal dialysis and prescribed phosphate binder therapy were eligible to participate. Participants were excluded from the study if they were unable to give consent, had hypercalcemia, were visually or hearing impaired or were expected to receive a renal transplant during the time of the study. After providing informed consent, patients kept a 3-day diet diary that included all foods and beverages consumed in addition to portion sizes. At the same time, patients documented the amount of phosphate binders taken with each meal. The phosphate content of the each meal was estimated using ESHA Food Processor SQL Software by a registered dietitian. Meal phosphate and binder variability were estimated by the Intra Class Correlation Coefficient (ICC) where 0 indicates maximal variability and 1 indicates no variability. Results Seventy-eight patients consented to participate in the study; 18 did not complete the study protocol. The patients were 60 (±17) years, predominately male (38/60) and Caucasian (51/60). Diabetic nephropathy was the most common cause of end stage kidney disease. The daily phosphate intake including snacks ranged from 959 ± 249 to 1144 ± 362 mg. The phosphate ICC by meal: breakfast 0.63, lunch 0.16; supper 0.27. The phosphate binder ICC by meal: breakfast 0.68, lunch 0.73, supper 0.67. Conclusion The standard prescription of a set number of phosphate binders with each meal is not supported by the data; patients do not appear to be adjusting their binders to match the meal phosphate content. An easy to use phosphate counting program that assists the patient in determining the appropriate amount of phosphate binder to take may enhance phosphate control.
dc.identifier.citationBMC Nephrology. 2015 Dec 09;16(1):205
dc.identifier.urihttp://dx.doi.org/10.1186/s12882-015-0205-3
dc.identifier.urihttp://hdl.handle.net/10393/33433
dc.language.rfc3066en
dc.rights.holderLeung et al.
dc.titleMeal phosphate variability does not support fixed dose phosphate binder schedules for patients treated with peritoneal dialysis: a prospective cohort study
dc.typeJournal Article

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail ImageThumbnail Image
Name:
12882_2015_Article_205.pdf
Size:
545.55 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail ImageThumbnail Image
Name:
license.txt
Size:
4.92 KB
Format:
Item-specific license agreed upon to submission
Description: